Josh Waldman's questions to Charles River Laboratories International Inc (CRL) leadership • Q1 2025
Question
Rob Catrol, on for Josh Waldman, asked if the reported growth in small and mid-sized biotech sales was consistent across all three business segments and if there were notable differences between small versus mid-sized biotech performance.
Answer
CFO Flavia Pease confirmed the encouraging growth from the overall biotech segment for the second consecutive quarter but stated that the company does not provide a more granular breakdown of performance between its small and mid-sized biotech clients.